DonCorleone77 Posted - 57 seconds ago

$LH Labcorp reports Q1 adjusted EPS $3.68, consensus $3.48 Reports Q1 revenue $3.18B, consensus $3.12B. "Labcorp's first quarter performance sets a strong foundation for the year ahead," said Adam Schechter, chairman and CEO of Labcorp. "We have a strong position as a partner of choice for health systems and regional/local laboratories, announcing or completing several transactions in the quarter. Additionally, we continue to harness science, technology and innovation as we expand Labcorp's test menu to meet patients' evolving needs. The Labcorp team will build off this momentum and continue to deliver value for customers, shareholders and employees as we further our mission to improve health and improve lives."

epsguid Posted - 29 minutes ago

$LH reported earnings of $3.68, consensus was $3.46 via @eWhispers #epsbeat http://eps.sh/d/lh

Stock_Titan Posted - 43 minutes ago

$LH Labcorp Announces 2024 First Quarter Results https://www.stocktitan.net/news/LH/labcorp-announces-2024-first-quarter-llzgrhyzazl8.html

DonCorleone77 Posted - 54 minutes ago

$LH Labcorp wins bid to purchase assets of Invitae for $239M Labcorp announced that it has been selected as the winning bidder for select assets of Invitae, a medical genetics company. Before the transaction can proceed, the court overseeing the process must issue an approval order following a hearing currently scheduled for May 6, 2024. Upon completion, Labcorp expects this transaction would generate approximately $275M-$300M in annual revenue with the vast majority in specialty testing areas such as oncology and rare diseases. The purchase price for the transaction is $239M. The transaction is anticipated to close in third quarter of 2024, subject to customary closing conditions for a transaction of this type, including applicable regulatory approvals. Through this transaction, Labcorp would acquire assets being auctioned through a voluntary bankruptcy protection process.

DonCorleone77 Posted - 9 hours ago

$NVTAQ $LH Invitae enters into agreement with Labcorp for $239M sale of business Invitae (NVTA) announced that Labcorp (LH) has been selected as the winning bidder in the Company's auction in its sale process under Section 363 of the U.S. Bankruptcy Code. Labcorp will acquire substantially all of the Company's assets on a going concern basis for $239 million in cash consideration, plus other non-cash consideration. The hearing to approve the sale is currently scheduled for May 6, 2024. With Court approval, as well as customary regulatory approvals and closing conditions, Labcorp and Invitae anticipate completing the sale process in the third quarter of 2024.

Stock_Titan Posted - 1 week ago

$LH Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw https://www.stocktitan.net/news/LH/labcorp-announces-first-of-its-kind-test-for-early-indication-of-9tsy182hil5l.html

DonCorleone77 Posted - 2 weeks ago

$LH Labcorp receives FDA EUA for Mpox PCR Test Home Collection Kit Labcorp announced today the FDA has granted Emergency Use Authorization, or EUA, for its Mpox PCR Test Home Collection Kit to aid in the diagnosis of infection with non-variola Orthopoxvirus, including the monkeypox virus that causes monkeypox, also known as mpox. The test is the first mpox at-home collection kit authorized by FDA and is available to physicians to order for patients 18 years of age or older who are suspected of mpox infection.

Stock_Titan Posted - 2 weeks ago

$LH Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit https://www.stocktitan.net/news/LH/labcorp-receives-fda-emergency-use-authorization-for-mpox-pcr-test-cer3xs0fs8ps.html

Stock_Titan Posted - 2 weeks ago

$LH Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs https://www.stocktitan.net/news/LH/labcorp-announces-expansion-of-precision-oncology-portfolio-to-p9k7d5sbb67i.html

Stock_Titan Posted - 2 weeks ago

$LH Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research https://www.stocktitan.net/news/LH/labcorp-launches-labcorp-r-plasma-detect-extending-leadership-into-mtaeekl3kfrp.html

insiderbuyingselling Posted - 3 weeks ago

$LH new insider selling: 3500 shares. http://insiderbuyingselling.com/?t=LH

DC729 Posted - 3 weeks ago

@ExNoose @Wax_Bean_futures $LH should acquire $PSNL

Stock_Titan Posted - 3 weeks ago

$LH Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research https://www.stocktitan.net/news/LH/labcorp-to-present-diverse-portfolio-of-precision-oncology-research-x1nrpo1td0dr.html

Stock_Titan Posted - 3 weeks ago

$LH Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp https://www.stocktitan.net/news/LH/xcell-biosciences-strengthens-cell-and-gene-therapy-collaboration-bc56c1iufzxp.html

insiderbuyingselling Posted - 03/29/24

$LH new insider selling: 3553 shares. http://insiderbuyingselling.com/?t=LH

Stock_Titan Posted - 03/29/24

$LH The Prelude Network® Names Labcorp Its Preferred Genetic Carrier Screening Lab https://www.stocktitan.net/news/LH/the-prelude-network-r-names-labcorp-its-preferred-genetic-carrier-lbnd4r6n5me6.html

OpenOutcrier Posted - 03/28/24

$OPK (+5.6% pre) $LH Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health. - SI https://ooc.bz/l/28972

DonCorleone77 Posted - 03/28/24

$LH $OPK Labcorp to acquire select assets of BioReference Health for $237.5M Labcorp (LH) and OPKO Health (OPK) announce that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health. Through this transaction, Labcorp will acquire BioReference Health's laboratory testing businesses focused on clinical diagnostics and reproductive and women's health across the United States outside of New York and New Jersey. This transaction includes patient service centers and certain customer contracts and operating assets. BioReference Health will continue to offer oncology and urology diagnostic services nationwide, as well as maintain its full operations in New York and New Jersey. When complete, the transaction is expected to provide patients, physicians and customers with greater access to Labcorp's comprehensive, high-quality laboratory services, scientific expertise and expanded testing capabilities....

Stock_Titan Posted - 03/28/24

$OPK $LH Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business https://www.stocktitan.net/news/OPK/labcorp-announces-acquisition-of-select-assets-of-bio-reference-k4ix9p5fuxi9.html

Stock_Titan Posted - 03/27/24

$LH Labcorp to Announce First Quarter Financial Results on April 25, 2024 https://www.stocktitan.net/news/LH/labcorp-to-announce-first-quarter-financial-results-on-april-25-d1xovi8l02qr.html

Stock_Titan Posted - 1 month ago

$LH Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials https://www.stocktitan.net/news/LH/labcorp-launches-p-tau217-blood-biomarker-test-to-accelerate-path-to-ouk39ybe84dx.html

EmmaRespond Posted - 1 month ago

Laboratory Corporation of America Holdings: A Promising Investment Opportunity to Consider $LH http://dlvr.it/T4L7zW

EmmaRespond Posted - 1 month ago

Laboratory Corporation of America Holdings: A Promising Investment Opportunity to Consider $LH http://dlvr.it/T4L6SK

Chark Posted - 1 month ago

$LH Ahhhh, a gap on the 180 at 204.89 that I didn't see before. Going to fill that first. Great entry after the fill. That is why you look at all time frames. Apologies.

tradingtwenty Posted - 1 month ago

$LH has trended 47 times in the past 24 hours (based on 5 minute intervals). Latest article on Mar 16, 2024 10:29 AM: Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted... Link: https://tradingtwenty.com/news/396214/labcorp-presents-new-research-demonstrating-clinical-impact-of-precision-diagnostics-in-guiding-biomarker-targeted-therapies-for-patients-with-epithelial-ovarian-cancer

Chark Posted - 1 month ago

$LH The Primary Elliott wave has not yet begun an Impulse wave on the daily but it has on the 180 so this will be off to the races imminently & this is where you want to catch the Impulse B wave, which can be quite long & strong. LRC is still in a strong uptrend. Great entry soon.

Chark Posted - 1 month ago

$LH This is the daily sequence counter, Elliott fractals, Darvas Box, & trendlines. The Darvas Box still has a sell signal, the sequence is only on a 4 & it will pop at 9, so it could breach that trendline, hit strong support & bounce, so give this entry a little latitude. As you can see the indicators are already beginning to turn up. Watch for the set ups people. Trade the charts. Math works.

Chark Posted - 1 month ago

$LH This is the 5yr daily for clarity. It is right at the bottom of the trendline in a bullish harami, nearing oversold, & ready to pop. It could see a couple of points lower but not many, unless it breaches the trendline. I think it holds.

Chark Posted - 1 month ago

$LH This is the LT chart & this is why you begin at the larger time frames. The Weinstein pattern is almost complete & it will begin a base imminently. The pattern is right at the pivotal "do or die" place of strong support, & all indicators are pointing to a reversal off of the bottom trendline. Great entry if it holds that line. All indicators still falling but not for long.

InsiderPeek Posted - 1 month ago

$LH Chief Marketing Officer Summy Amy B. sold 227 shares for $49.6k (ownership down 5.56%) insiderpeek.com/company/LH